E
Ema Yoshioka
Researcher at Memorial University of Newfoundland
Publications - 29
Citations - 453
Ema Yoshioka is an academic researcher from Memorial University of Newfoundland. The author has contributed to research in topics: Glioma & Medicine. The author has an hindex of 10, co-authored 22 publications receiving 260 citations. Previous affiliations of Ema Yoshioka include Osaka University.
Papers
More filters
Journal ArticleDOI
Lesion location implemented magnetic resonance imaging radiomics for predicting IDH and TERT promoter mutations in grade II/III gliomas.
Hideyuki Arita,Manabu Kinoshita,Atsushi Kawaguchi,Masamichi Takahashi,Yoshitaka Narita,Yuzo Terakawa,Naohiro Tsuyuguchi,Naohiro Tsuyuguchi,Yoshiko Okita,Masahiro Nonaka,Shusuke Moriuchi,Masatoshi Takagaki,Yasunori Fujimoto,Junya Fukai,Shuichi Izumoto,Kenichi Ishibashi,Yoshikazu Nakajima,Tomoko Shofuda,Daisuke Kanematsu,Ema Yoshioka,Yoshinori Kodama,Masayuki Mano,Kanji Mori,Koichi Ichimura,Yonehiro Kanemura +24 more
TL;DR: Conventional MRI-based radiomics is one of the most promising strategies that may lead to a non-invasive diagnostic technique for molecular characterization of grade II/III gliomas.
Journal ArticleDOI
Radiomics and MGMT promoter methylation for prognostication of newly diagnosed glioblastoma.
Takahiro Sasaki,Manabu Kinoshita,Koji Fujita,Junya Fukai,Nobuhide Hayashi,Yuji Uematsu,Yoshiko Okita,Masahiro Nonaka,Shusuke Moriuchi,Takehiro Uda,Naohiro Tsuyuguchi,Naohiro Tsuyuguchi,Hideyuki Arita,Kanji Mori,Kenichi Ishibashi,Koji Takano,Namiko Nishida,Tomoko Shofuda,Ema Yoshioka,Daisuke Kanematsu,Yoshinori Kodama,Masayuki Mano,Naoyuki Nakao,Yonehiro Kanemura +23 more
TL;DR: A magnetic resonance imaging (MRI)-based radiomic model for stratifying prognostic subgroups of newly diagnosed glioblastoma (GBM) patients and predicting O (6)-methylguanine-DNA methyltransferase promotor methylation (pMGMT-met) status of the tumor was established.
Journal ArticleDOI
Prediction of IDH and TERT promoter mutations in low-grade glioma from magnetic resonance images using a convolutional neural network.
Ryohei Fukuma,Takufumi Yanagisawa,Manabu Kinoshita,Takashi Shinozaki,Takashi Shinozaki,Hideyuki Arita,Hideyuki Arita,Atsushi Kawaguchi,Masamichi Takahashi,Yoshitaka Narita,Yuzo Terakawa,Naohiro Tsuyuguchi,Yoshiko Okita,Masahiro Nonaka,Shusuke Moriuchi,Masatoshi Takagaki,Yasunori Fujimoto,Junya Fukai,Shuichi Izumoto,Kenichi Ishibashi,Yoshikazu Nakajima,Tomoko Shofuda,Daisuke Kanematsu,Ema Yoshioka,Yoshinori Kodama,Masayuki Mano,Kanji Mori,Koichi Ichimura,Yonehiro Kanemura,Haruhiko Kishima +29 more
TL;DR: The pretrained CNN texture features capture the information of IDH and TERT genotypes in grade II/III gliomas better than the conventional radiomic features.
Journal ArticleDOI
Enhancement of Cancer-Specific Protoporphyrin IX Fluorescence by Targeting Oncogenic Ras/MEK Pathway.
Ema Yoshioka,Vipin Shankar Chelakkot,Maria Licursi,Suzette G Rutihinda,Jayoti Som,Leena Derwish,Justin J. King,Theerawat Pongnopparat,Karen M. Mearow,Mani Larijani,Ann M. Dorward,Kensuke Hirasawa +11 more
TL;DR: Protoporphyrin IX (PpIX) is an endogenous fluorescent molecule that selectively accumulates in cancer cells treated with the heme precursor 5-aminolevulinic acid (5-ALA), and inhibition of oncogenic Ras/MEK significantly enhances PpIX accumulation in vitro and in vivo in a cancer-specific manner.
Journal ArticleDOI
11C-methinine uptake correlates with MGMT promoter methylation in nonenhancing gliomas
Yoshiko Okita,Masahiro Nonaka,Tomoko Shofuda,Daisuke Kanematsu,Ema Yoshioka,Yoshinori Kodama,Masayuki Mano,Shin Nakajima,Yonehiro Kanemura +8 more
TL;DR: A higher uptake in (11)C-methionine PET could be a useful tool to detect MGMT promoter methylation in nonenhancing glioma.